Trandolaprilat

This classification denotes an ace inhibitor with the molecular formula C22H30N2O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier RR6866VL0O, chemically known as 1h-indol-2-carboxylic acid, 1-(2-((1-carboxy-3-phenylpropyl)amino)-1-oxopropyl)octahydro- but generally known as trandolaprilat, which bears US NIH Compound Identifier 128549. European Medicines Agency schedules Trandolaprilat in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11213MIG. The term TRANDOLAPRILAT is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 3, No. 3, 1989, List 29). TRANDOLAPRILAT is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule trandolaprilat under HS 29339990 and SITC 51577. As of Q4 2014, TRANDOLAPRILAT remains the US FDA Preferred Term for this commodity. Trandolaprilat bears US NLM identifiers UMLS ID C0165477 and NCI Concept Code C72913. SMILES: O=C(N1C2C(CC1C(=O)O)CCCC2)C(NC(CCc1ccccc1)C(=O)O)C.